PRTN3 and rheumatoid arthritis: Considering the great importance given to serological status in the 2010 ACR/EULAR classification criteria for RA, the relevance of seropositivity against ACPA specifically is not surprising, since seronegative patients take longer to receive a diagnosis and also have greater disease activity [8].